Related Experiment Video

Updated: Jan 30, 2026

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
05:57

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

1.0K

Expression of cancer-testis antigens in esophageal cancer and their progress in immunotherapy

Yujie Zhang1, Yuxin Zhang2, Li Zhang3

  • 1Department of Oncology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, Wuhan, 430030, Hubei, China.

Journal of Cancer Research and Clinical Oncology
|January 19, 2019
PubMed
Abstract

Insights

Cancer-testis antigens (CTA) like MAGE-A, NY-ESO-1, LAGE-1, and TTK show promise for esophageal cancer immunotherapy. While their prognostic value is debated, their expression and ability to induce tumor cell killing offer new therapeutic strategies.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Esophageal cancer presents a significant health challenge in China, characterized by low survival rates due to late detection and limited effective treatments.
  • Traditional therapies often fall short for advanced stages, highlighting the need for novel approaches like immunotherapy.
  • Cancer-testis antigens (CTA) are tumor-related antigens with high immunogenicity and restricted expression, making them attractive targets for cancer immunotherapy.

Purpose of the Study:

  • To review the expression patterns and prognostic significance of MAGE-A, NY-ESO-1, LAGE-1, and TTK in esophageal cancer.
  • To explore the potential of these CTA as targets for immunotherapy in esophageal cancer.
  • To summarize recent advancements in CTA-based immunotherapy for esophageal cancer.

Main Methods:

  • A comprehensive literature review of relevant studies was conducted using PubMed.
  • Analysis focused on the expression, prognostic value, and immunotherapeutic potential of specific CTA in esophageal cancer.

Main Results:

  • MAGE-A, NY-ESO-1, LAGE-1, and TTK are frequently expressed in esophageal cancer.
  • These CTA can stimulate cytotoxic T lymphocyte (CTL) responses against tumor cells.
  • Clinical trials indicate that immunotherapy for esophageal cancer is both safe and effective, suggesting a promising future therapeutic avenue.

Conclusions:

  • The expression and prognostic value of MAGE-A, NY-ESO-1, LAGE-1, and TTK in esophageal cancer warrant further investigation.
  • CTA-based immunotherapy represents a viable and emerging strategy for treating esophageal cancer.
  • Continued research into CTA is crucial for developing more effective esophageal cancer treatments.
Keywords:
Cancer–testis antigensEsophageal cancerLAGE-1MAGE-ANY-ESO-1TTK

More Related Videos

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

16.0K
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression09:25

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

27.6K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.2K
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.4K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.0K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.9K